Genetic Analysis Can Surrogate the Treatment Strategies in Patients with Pancreatic Cancer

참고문헌 (7)

1. 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
2. He J, "2564 resected periampullary adenocarcinomas at a single institution: trends over three decades", HPB (Oxford), 16, pp.83~90 (2014)
3. Kyong-Ah Yoon, "Comprehensive Cancer Panel Sequencing Defines Genetic Diversity and Changes in the Mutational Characteristics of Pancreatic Cancer Patients Receiving Neoadjuvant Treatment", Gut and Liver, 13(6), pp.683~689 (2019), 거트앤리버 소화기연관학회협의회[DOI]
4. Cancer Genome Atlas Research Network, "Integrated genomic characterization of pancreatic ductal adenocarcinoma", Cancer Cell, 32, pp.185~203 (2017)
5. Dimitrakopoulos C, "Identification and validation of a biomarker signature in patients with resectable pancreatic cancer via genome-wide screening for functional genetic variants", JAMA Surg, 154, pp.e190484~ (2019)
6. Aguirre AJ, "Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine", Cancer Discov, 8, pp.1096~1111 (2018)
7. Aung KL, "Genomics-driven precision medicine for advanced pancreatic cancer : early results from the COMPASS trial", Clin Cancer Res, 24, pp.1344~1354 (2018)

관련 논문AI추천